According to Quick-Med, the Nimbus is a next-generation wound care technology that is non-toxic, long-lasting and not blocked by organics such as blood, urine and perspiration.
Ladd Greeno, CEO of Quick-Med, said: “We are excited to team with Foster to incorporate our Nimbus technology in catheters. Foster is a respected leader developing advanced biomedical materials to meet the requirements of medical device manufacturers. This collaboration will leverage Nimbus technology to a next generation of antimicrobial catheters to address growing infection concerns.”